Pathways to Prevention Workshop: Can Physical Activity Improve the Health of Wheelchair Users? (Day 2)
The 2010 census estimated that 3.6 million Americans use a wheeled mobility device, such as a manual wheelchair, motorized wheelchair, or scooter. This number is projected to be four times higher in 2020. Individuals who use wheeled mobility devices often experience distinct health challenges and poor health outcomes and may also encounter barriers to accessing preventive health care and getting sufficient physical activity. Physical activity interventions are likely to have wide-ranging impacts on the overall health of people who use wheeled mobility devices and may improve their workforce participation, independence, and...
Source: Videocast - All Events - August 12, 2020 Category: General Medicine Tags: Upcoming Events Source Type: video

Pathways to Prevention Workshop: Can Physical Activity Improve the Health of Wheelchair Users? (Day 1)
The 2010 census estimated that 3.6 million Americans use a wheeled mobility device, such as a manual wheelchair, motorized wheelchair, or scooter. This number is projected to be four times higher in 2020. Individuals who use wheeled mobility devices often experience distinct health challenges and poor health outcomes and may also encounter barriers to accessing preventive health care and getting sufficient physical activity. Physical activity interventions are likely to have wide-ranging impacts on the overall health of people who use wheeled mobility devices and may improve their workforce participation, independence, and...
Source: Videocast - All Events - August 12, 2020 Category: General Medicine Tags: Upcoming Events Source Type: video

NIH HEAL Initiative Workshop on Myofascial Pain (Day 2)
It is estimated that 30 to 85 percent of patients with musculoskeletal pain are affected by myofascial pain syndrome (MPS) — pain originating from muscles and/or associated soft tissues such as fascia. Interactions between fascia and muscles remain mostly unknown and there is a strong need to address the contributions of the myofascial tissues to chronic pain. This represents one of the last “ unturned stones ” of all the tissue types involved in musculoskeletal pain. The National Center for Complementary and Integrative Health and the National Institute of Biomedical Imaging and Bioengineering are proud to join forc...
Source: Videocast - All Events - August 4, 2020 Category: General Medicine Tags: Upcoming Events Source Type: video

NIH HEAL Initiative Workshop on Myofascial Pain (Day 1)
It is estimated that 30 to 85 percent of patients with musculoskeletal pain are affected by myofascial pain syndrome (MPS) — pain originating from muscles and/or associated soft tissues such as fascia. Interactions between fascia and muscles remain mostly unknown and there is a strong need to address the contributions of the myofascial tissues to chronic pain. This represents one of the last “ unturned stones ” of all the tissue types involved in musculoskeletal pain. The National Center for Complementary and Integrative Health and the National Institute of Biomedical Imaging and Bioengineering are proud to join forc...
Source: Videocast - All Events - August 4, 2020 Category: General Medicine Tags: Upcoming Events Source Type: video

Neuron cells in the central amygdala of a mouse brain
. Red, magenta and yellow cells (but not green or blue) are part of a collection of neurons called the CeAga that has potent pain-suppression abilities. [Research supported by a U.S. National Science Foundation Graduate Research ...This is an NSF Multimedia Gallery item. (Source: NSF Multimedia Gallery)
Source: NSF Multimedia Gallery - July 21, 2020 Category: Science Source Type: video

NIH HEAL Myofascial Pain Workshop (Day 2)
It is estimated that 30 to 85 percent of patients with musculoskeletal pain are affected by myofascial pain syndrome (MPS) — pain originating from muscles and/or associated soft tissues such as fascia. Interactions between fascia and muscles remain mostly unknown and there is a strong need to address the contributions of the myofascial tissues to chronic pain. This represents one of the last “ unturned stones ” of all the tissue types involved in musculoskeletal pain. The National Center for Complementary and Integrative Health and the National Institute of Biomedical Imaging and Bioengineering are proud to join forc...
Source: Videocast - All Events - June 30, 2020 Category: General Medicine Tags: Upcoming Events Source Type: video

NIH HEAL Myofascial Pain Workshop (Day 1)
It is estimated that 30 to 85 percent of patients with musculoskeletal pain are affected by myofascial pain syndrome (MPS) — pain originating from muscles and/or associated soft tissues such as fascia. Interactions between fascia and muscles remain mostly unknown and there is a strong need to address the contributions of the myofascial tissues to chronic pain. This represents one of the last “ unturned stones ” of all the tissue types involved in musculoskeletal pain. The National Center for Complementary and Integrative Health and the National Institute of Biomedical Imaging and Bioengineering are proud to join forc...
Source: Videocast - All Events - June 30, 2020 Category: General Medicine Tags: Upcoming Events Source Type: video

AFM and GBS state of the science
The purpose of this workshop is to bring together experts in research and treatment of two acute paralytic neurological conditions, acute flaccid myelitis (AFM) and Guillain Barre syndrome (GBS), to identify gaps in scientific knowledge that, if filled, could advance understanding of pathological mechanisms and accelerate the development of effective prevention and treatment strategies. This is a short " pre-meeting " event being held in advance of a larger in person meeting.For more information go tohttps://meetings.ninds.nih.gov/meetings/AFMandGBS/Air date: 5/7/2020 2:00:00 PM (Source: Videocast - All Events)
Source: Videocast - All Events - April 21, 2020 Category: General Medicine Tags: Upcoming Events Source Type: video

Decision-Making and Computational Psychiatry: An Explanatory and Pragmatic Perspective
Dr. Martin Paulus, Scientific Director and President of the Laureate Institute for Brain Research (LIBR), will be the guest speaker in the NIMH Director ’ s Innovation Speaker Series, which focuses on innovation, invention, and scientific discovery. Dr. Paulus is the Deputy Editor of JAMA Psychiatry and serves on several editorial boards of top-tier psychiatric journals. He has served on numerous NIH and international study sections. At LIBR, Dr. Paulus focuses on using neuroscience approaches to develop better assessments for diagnosis and prognosis of mental health problems and to develop novel interventions based on a...
Source: Videocast - All Events - March 13, 2020 Category: General Medicine Tags: Upcoming Events Source Type: video

NEI Audacious Goals: Cytoplasmic material exchange between sensory neurons in vivo
Dr. Wallace is Director of Vision Sciences and Chair of the Vision Science Research Program at the Toronto Western Research Institute/University Health Network. She holds appointments in the Departments of Ophthalmology and Vision Sciences and Laboratory Medicine and Pathobiology, University of Toronto. A molecular and developmental biologist by training, she is recognized for her work on the role of Hedgehog signaling in neural progenitor proliferation in the central nervous system. Her lab is now applying this knowledge towards investigating the role of morphogen signaling in tumorigenesis and the development of cell-bas...
Source: Videocast - All Events - February 24, 2020 Category: General Medicine Tags: Upcoming Events Source Type: video

Cellular Therapy Targeting Malignant Brain Tumors
CCR Grand Rounds Duane A. Mitchell, M.D., Ph.D. is Co-Director of the Preston A. Wells Jr. Center for Brain Tumor Therapy and Director of the UF Brain Tumor Immunotherapy Program. He is the Phyllis Kottler Friedman Professor in the Department of Neurosurgery and the State of Florida Endowed Cancer Research Chair at the University of Florida College of Medicine. Dr. Mitchell graduated from Rutgers College in New Brunswick, New Jersey with a bachelor ’ s degree in biology before receiving his medical degree and doctorate degree in immunology from Duke University in Durham, North Carolina in 2001. He completed post-graduate...
Source: Videocast - All Events - February 24, 2020 Category: General Medicine Tags: Upcoming Events Source Type: video

AGI Seminar in Neuroregeneration
Dr. Wallace is Director of Vision Sciences and Chair of the Vision Science Research Program at the Toronto Western Research Institute/University Health Network. She holds appointments in the Departments of Ophthalmology and Vision Sciences and Laboratory Medicine and Pathobiology, University of Toronto. A molecular and developmental biologist by training, she is recognized for her work on the role of Hedgehog signaling in neural progenitor proliferation in the central nervous system. Her lab is now applying this knowledge towards investigating the role of morphogen signaling in tumorigenesis and the development of cell-bas...
Source: Videocast - All Events - February 18, 2020 Category: General Medicine Tags: Upcoming Events Source Type: video

Novel Target Discovery and Psychosocial Intervention Development Workshop (Day 2)
Despite tremendous advances in basic neuroscience and behavioral science, there is still a major need for more effective treatments for many people living with mental illness. Part of NIMH ’ s mission is to speed up the pace of discovery of new validated targets, such as biological, behavioral, and clinical markers of specific mental illnesses, to help aid in the development of new therapeutic treatments for mental illness. The overarching goal of the workshop is to accelerate research that supports the identification of novel targets to develop and improve non-pharmacological interventions (such as cognitive, behaviora...
Source: Videocast - All Events - February 6, 2020 Category: General Medicine Tags: Upcoming Events Source Type: video

Novel Target Discovery and Psychosocial Intervention Development Workshop (Day 1)
Despite tremendous advances in basic neuroscience and behavioral science, there is still a major need for more effective treatments for many people living with mental illness. Part of NIMH ’ s mission is to speed up the pace of discovery of new validated targets, such as biological, behavioral, and clinical markers of specific mental illnesses, to help aid in the development of new therapeutic treatments for mental illness. The overarching goal of the workshop is to accelerate research that supports the identification of novel targets to develop and improve non-pharmacological interventions (such as cognitive, behaviora...
Source: Videocast - All Events - February 6, 2020 Category: General Medicine Tags: Upcoming Events Source Type: video

Pathways to Prevention Workshop: Can Physical Activity Improve the Health of Wheelchair Users? (Day 1)
The 2010 census estimated that 3.6 million Americans use a wheeled mobility device, such as a manual wheelchair, motorized wheelchair, or scooter. This number is projected to be four times higher by 2020. Individuals who use wheeled mobility devices often experience poorer health outcomes compared to the general population. There are some distinct health challenges related to the physical effects of long-term wheelchair use, such as shoulder overuse injuries, skin breakdown, and urinary tract disorders. Wheelchair users may also encounter barriers to accessing preventive health care and getting sufficient physical activity...
Source: Videocast - All Events - November 4, 2019 Category: General Medicine Tags: Upcoming Events Source Type: video